A population-based study of stimulant drug treatment of ADHD and academic progress in children

Pediatrics

Volumn 130, Issue 1, 2012, Pages

  Zoëga, Helga ^a,b   Rothman, Kenneth J ^c,d   Huybrechts, Krista F ^e   Ólafsson, Örn ^a   Baldursson, Gísli ^f   Almarsdóttir, Anna B ^a   Jónsdóttir, Sólveig ^a,f   Halldórsson, Matthías ^f   Hernández Diaz, Sonia ^g   Valdimarsdóttir, Unnur A ^a  

^a UNIVERSITY OF ICELAND   (Iceland)

^b MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^c RTI HEALTH SOLUTIONS   (United States)

^d BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^e BRIGHAM AND WOMEN S HOSPITAL   (United States)

^f LANDSPITALI UNIVERSITY HOSPITAL   (Iceland)

^g HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Academic performance; Attention deficit hyperactivity disorder; Children; Pharmacoepidemiology; Stimulant treatment

Indexed keywords

ADRENERGIC RECEPTOR STIMULATING AGENT; AMPHETAMINE; ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; ATOMOXETINE; HYPNOTIC AGENT; METHYLPHENIDATE; NEUROLEPTIC AGENT; PSYCHOTROPIC AGENT; SEDATIVE AGENT;

ACADEMIC ACHIEVEMENT; ARTICLE; ATTENTION DEFICIT DISORDER; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE REGISTRY; DRUG EFFICACY; DRUG EXPOSURE; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POPULATION RESEARCH; PRESCHOOL CHILD; PRIORITY JOURNAL; PROBABILITY; RURAL AREA; TREATMENT RESPONSE; URBAN AREA;

EID: 84863523521     PISSN: 00314005     EISSN: 10984275     Source Type: Journal    
DOI: 10.1542/peds.2011-3493     Document Type: Article

References (40)

1. Centers for Disease Control and Prevention. Mental health in the United States: prevalence of diagnosis and medication treatment for attention-deficit/hyperactivity disorder-United States, 2003. MMWR Mortal Wkly Rep. 2005;54(34):842-847
2. Polanczyk G, de Lima MS, Horta BL, Biederman J, Rohde LA. The worldwide prevalence of ADHD: a systematic review and metaregression analysis. Am J Psychiatry. 2007;164(6):942-948 (Pubitemid 46972911)
3. Zoëga H, Baldursson G, Halldórsson M. Use of methylphenidate among children in Iceland 1989-2006 [in Icelandic]. Laeknabladid. 2007;93(12):825-832
4. Zoëga H, Baldursson G, Hrafnkelsson B, Almarsdóttir AB, Valdimarsdóttir U, Halldórsson M. Psychotropic drug use among Icelandic children: a nationwide population-based study. J Child Adolesc Psychopharmacol. 2009;19(6):757-764
5. Castle L, Aubert RE, Verbrugge RR, Khalid M, Epstein RS. Trends in medication treatment for ADHD. J Atten Disord. 2007;10(4):335-342
6. Zuvekas SH, Vitiello B, Norquist GS. Recent trends in stimulant medication use among U.S. children. Am J Psychiatry. 2006;163(4):579-585 (Pubitemid 44464565)
7. Hsia Y, Maclennan K. Rise in psychotropic drug prescribing in children and adolescents during 1992-2001: a population-based study in the UK. Eur J Epidemiol. 2009;24(4):211-216
8. Faber A, de Jong-van den Berg LT, van den Berg PB, Tobi H. Psychotropic co-medication among stimulant-treated children in The Netherlands. J Child Adolesc Psychopharmacol. 2005;15(1):38-43 (Pubitemid 40365912)
9. Knellwolf AL, Deligne J, Chiarotti F, et al. Prevalence and patterns of methylphenidate use in French children and adolescents. Eur J Clin Pharmacol. 2008;64(3):311-317
10. Scheffler RM, Hinshaw SP, Modrek S, Levine P. The global market for ADHD medications. Health Aff (Millwood). 2007;26(2):450-457
11. Greenhill LL, Halperin JM, Abikoff H. Stimulant medications. J Am Acad Child Adolesc Psychiatry. 1999;38(5):503-512 (Pubitemid 29203465)
12. The MTA Cooperative Group; Multimodal Treatment Study of Children with ADHD. A 14-month randomized clinical trial of treatment strategies for attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999;56(12):1073-1086
13. Conner D. Stimulants. In: Barkley R, ed. Attention-Deficit Hyperactivity Disorder: A Handbook for Diagnosis and Treatment. 3rd ed. New York, NY: The Guilford Press; 2005:608-647
14. Brown RT, Amler RW, Freeman WS, et al American Academy of Pediatrics Committee on Quality Improvement; American Academy of Pediatrics Subcommittee on Attention-Deficit/Hyperactivity Disorder. Treatment of attention-deficit/ hyperactivity disorder: overview of the evidence. Pediatrics. 2005;115(6). Available at: www.pediatrics.org/cgi/content/full/115/6/e749
15. MTA Cooperative Group. National Institute of Mental Health Multimodal Treatment Study of ADHD follow-up: changes in effectiveness and growth after the end of treatment. Pediatrics. 2004;113(4):762-769
16. Swanson J, Baler RD, Volkow ND. Understanding the effects of stimulant medications on cognition in individuals with attentiondeficit hyperactivity disorder: a decade of progress. Neuropsychopharmacology. 2011;36(1):207-226
17. Pietrzak RH, Mollica CM, Maruff P, Snyder PJ. Cognitive effects of immediate-release methylphenidate in children with attentiondeficit/ hyperactivity disorder. Neurosci Biobehav Rev. 2006;30(8):1225-1245 (Pubitemid 44855160)
18. Bedard AC, Jain U, Johnson SH, Tannock R. Effects of methylphenidate on working memory components: influence of measurement. J Child Psychol Psychiatry. 2007;48(9):872-880 (Pubitemid 47244900)
19. James RS, Sharp WS, Bastain TM, et al. Double-blind, placebo-controlled study of single-dose amphetamine formulations in ADHD. J Am Acad Child Adolesc Psychiatry. 2001;40(11):1268-1276 (Pubitemid 32995794)
20. Gorman EB, Klorman R, Thatcher JE, Borgstedt AD. Effects of methylphenidate on subtypes of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry. 2006;45(7):808-816 (Pubitemid 43932907)
21. Scheffler RM, Brown TT, Fulton BD, Hinshaw SP, Levine P, Stone S. Positive association between attention-deficit/ hyperactivity disorder medication use and academic achievement during elementary school. Pediatrics. 2009;123(5):1273-1279
22. Molina BS, Hinshaw SP, Swanson JM, et al MTA Cooperative Group. The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry. 2009;48(5):484-500
23. Barbaresi WJ, Katusic SK, Colligan RC, Weaver AL, Jacobsen SJ. Modifiers of longterm school outcomes for children with attention-deficit/hyperactivity disorder: does treatment with stimulant medication make a difference? Results from a populationbased study. J Dev Behav Pediatr. 2007;28(4):274-287 (Pubitemid 47256030)
24. Zoëga H, Furu K, Halldórsson M, Thomsen PH, Sourander A, Martikainen JE. Use of ADHD drugs in the Nordic countries: a population-based comparison study. Acta Psychiatr Scand. 2011;123(5):360-367
25. WHO. WHO Collaborating Centre for Drug Statistics Methodology: ATC/DDD Index. Oslo, Norway: World Health Organization; 2008
26. Baldursson G, Magnusson P, Haraldsson HM, Halldorsson M. Vinnulag vio greiningu og meofero athyglisbrests meoofvirkni (ADHD) [Clinical Guidelines for Diagnosing and Treating ADHD]. Seltjarnarnes, Iceland: Directorate of Health in Iceland; 2007
27. Icelandic Medicines Agency. Summaries of Product Characteristics (SPC). Seltjarnarnes, Iceland: Iceland Medicines Control Agency; 2003-2008
28. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th ed. Washington, DC: American Psychiatric Association; 2000
29. Greenland S. Applications of Stratified Analysis Methods. In: Rothman KJ, Greenland S, Lash TL, eds. Modern Epidemiology. 3rd ed. Philadelphia, PA: Lippincott Williams & Wilkins; 2008
30. Zou G. A modified poisson regression approach to prospective studies with binary data. Am J Epidemiol. 2004;159(7):702-706 (Pubitemid 38405384)
31. Fox T, Fink A, Lash T. Selection bias. In: Fox T, Fink A, Lash T, eds. Applying Quantitative Bias Analysis to Epidemiologic Data. New York, NY: Springer; 2009:43-59
32. Hechtman L, Abikoff H, Klein RG, et al. Academic achievement and emotional status of children with ADHD treated with long-term methylphenidate and multimodal psychosocial treatment. J Am Acad Child Adolesc Psychiatry. 2004;43(7):812-819 (Pubitemid 38808486)
33. Polderman TJ, Boomsma DI, Bartels M, Verhulst FC, Huizink AC. A systematic review of prospective studies on attention problems and academic achievement. Acta Psychiatr Scand. 2010;122(4):271-284
34. Loe IM, Feldman HM. Academic and educational outcomes of children with ADHD. J Pediatr Psychol. 2007;32(6):643-654 (Pubitemid 47356042)
35. Faraone SV, Biederman J, Lehman BK, et al. Intellectual performance and school failure in children with attention deficit hyperactivity disorder and in their siblings. J Abnorm Psychol. 1993;102(4):616-623 (Pubitemid 23333504)
36. Landerl K, Fussenegger B, Moll K, Willburger E. Dyslexia and dyscalculia: two learning disorders with different cognitive profiles. J Exp Child Psychol. 2009;103(3):309-324
37. Gaub M, Carlson CL. Gender differences in ADHD: a meta-analysis and critical review. J Am Acad Child Adolesc Psychiatry. 1997;36(8):1036-1045 (Pubitemid 27337654)
38. Gershon J. A meta-analytic review of gender differences in ADHD. J Atten Disord. 2002;5(3):143-154 (Pubitemid 44844210)
39. MTA Cooperative Group. Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder. Arch Gen Psychiatry. 1999;56(12):1088-1096
40. Günther T, Herpertz-Dahlmann B, Konrad K. Sex differences in attentional performance and their modulation by methylphenidate in children with attentiondeficit/hyperactivity disorder. J Child Adolesc Psychopharmacol. 2010;20(3):179-186